Skip to content
October 29, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
The Five-Year Frontier: How Scientists Are Unlocking the Secrets of the Human Brain Through "Time-Warp" Organoids the-five-year-frontier-how-scientists-are-unlocking-the-secrets-of-the-human-brain-through-time-warp-organoids
  • Genomics and Precision Medicine

The Five-Year Frontier: How Scientists Are Unlocking the Secrets of the Human Brain Through "Time-Warp" Organoids

Nana September 4, 2026
In a landmark achievement that blurs the line between biological reality and laboratory innovation, a team of...
Read More Read more about The Five-Year Frontier: How Scientists Are Unlocking the Secrets of the Human Brain Through "Time-Warp" Organoids
Honoring the Architects of Discovery: ASHG Announces 2026 Professional Award Recipients honoring-the-architects-of-discovery-ashg-announces-2026-professional-award-recipients
  • Genomics and Precision Medicine

Honoring the Architects of Discovery: ASHG Announces 2026 Professional Award Recipients

Azzam Bilal Chamdy September 4, 2026
ROCKVILLE, Md. — The American Society of Human Genetics (ASHG) has officially unveiled its 2026 Professional Awards,...
Read More Read more about Honoring the Architects of Discovery: ASHG Announces 2026 Professional Award Recipients
Finding Solace in the Science of Care: A Personal Journey of Legacy and Detection finding-solace-in-the-science-of-care-a-personal-journey-of-legacy-and-detection
  • Survivorship and Post-Treatment

Finding Solace in the Science of Care: A Personal Journey of Legacy and Detection

Iffa Jayyana September 4, 2026
By Editorial Staff | February 3, 2026 For millions of women, the annual mammogram is a threshold—a...
Read More Read more about Finding Solace in the Science of Care: A Personal Journey of Legacy and Detection
Argo Biopharmaceutical’s BW-20805 Shows Promising Mid-Stage Results, Poised to Disrupt Highly Competitive Hereditary Angioedema Market argo-biopharmaceuticals-bw-20805-shows-promising-mid-stage-results-poised-to-disrupt-highly-competitive-hereditary-angioedema-market
  • Medical Research and Clinical Trials

Argo Biopharmaceutical’s BW-20805 Shows Promising Mid-Stage Results, Poised to Disrupt Highly Competitive Hereditary Angioedema Market

Iffa Jayyana September 4, 2026
Berlin, Germany – Argo Biopharmaceutical has unveiled compelling Phase II data for its novel hereditary angioedema (HAE)...
Read More Read more about Argo Biopharmaceutical’s BW-20805 Shows Promising Mid-Stage Results, Poised to Disrupt Highly Competitive Hereditary Angioedema Market
AbbVie’s Etentamig Challenges Multiple Myeloma Treatment Landscape with Superior Safety Profile abbvies-etentamig-challenges-multiple-myeloma-treatment-landscape-with-superior-safety-profile
  • Treatment Innovations

AbbVie’s Etentamig Challenges Multiple Myeloma Treatment Landscape with Superior Safety Profile

Ammar Sabilarrohman September 4, 2026
By Jonathan Gardner Published September 4, 2026 In the rapidly evolving arena of hematologic oncology, the pursuit...
Read More Read more about AbbVie’s Etentamig Challenges Multiple Myeloma Treatment Landscape with Superior Safety Profile
Redefining the First-Line Paradigm: The Impact of DESTINY-Breast09 on HER2-Positive Breast Cancer Care redefining-the-first-line-paradigm-the-impact-of-destiny-breast09-on-her2-positive-breast-cancer-care
  • Clinical Oncology Education

Redefining the First-Line Paradigm: The Impact of DESTINY-Breast09 on HER2-Positive Breast Cancer Care

Rifan Muazin September 4, 2026
The landscape of metastatic HER2-positive breast cancer is undergoing a seismic shift. For over a decade, the...
Read More Read more about Redefining the First-Line Paradigm: The Impact of DESTINY-Breast09 on HER2-Positive Breast Cancer Care
The 2026 Biotech Funding Landscape: A Deep Dive into the Top 50 Private Titans the-2026-biotech-funding-landscape-a-deep-dive-into-the-top-50-private-titans
  • Chemotherapy and Targeted Therapy

The 2026 Biotech Funding Landscape: A Deep Dive into the Top 50 Private Titans

Nila Kartika Wati September 4, 2026
The biotechnology sector in 2026 has entered a period of extraordinary maturation, characterized by a fundamental shift...
Read More Read more about The 2026 Biotech Funding Landscape: A Deep Dive into the Top 50 Private Titans
The Data-Driven War on Cancer: METAvivor Urges Congress to Secure Robust Funding for National Cancer Registries Through 2027 the-data-driven-war-on-cancer-metavivor-urges-congress-to-secure-robust-funding-for-national-cancer-registries-through-2027
  • Patient Advocacy and Support

The Data-Driven War on Cancer: METAvivor Urges Congress to Secure Robust Funding for National Cancer Registries Through 2027

Iffa Jayyana September 4, 2026
In the complex landscape of oncology, data is as critical as the medicine itself. As the United...
Read More Read more about The Data-Driven War on Cancer: METAvivor Urges Congress to Secure Robust Funding for National Cancer Registries Through 2027
Advocacy in Crisis: METAvivor Challenges Proposed Rescission of PCORI Trust Fund advocacy-in-crisis-metavivor-challenges-proposed-rescission-of-pcori-trust-fund
  • Metastatic Breast Cancer Research

Advocacy in Crisis: METAvivor Challenges Proposed Rescission of PCORI Trust Fund

Muslim September 4, 2026
Introduction: A Critical Juncture for Patient-Centered Science In the landscape of medical research, the Patient-Centered Outcomes Research...
Read More Read more about Advocacy in Crisis: METAvivor Challenges Proposed Rescission of PCORI Trust Fund
From Seedling to Science: How One Student’s Peanut Became a Breakthrough in Classroom Research from-seedling-to-science-how-one-students-peanut-became-a-breakthrough-in-classroom-research
  • Genomics and Precision Medicine

From Seedling to Science: How One Student’s Peanut Became a Breakthrough in Classroom Research

Raul Delapena Setiawan September 4, 2026
Main Facts: The Wiregrass Peanut Project In the heart of Alabama’s Wiregrass region, where agriculture serves as...
Read More Read more about From Seedling to Science: How One Student’s Peanut Became a Breakthrough in Classroom Research

Posts pagination

Previous 1 … 298 299 300 301 302 303 304 … 835 Next

Recent Posts

  • Unmasking the Silent Threat: Groundbreaking St. Jude Research Reveals Genetic Blueprint of Secondary Cancers in Childhood Survivors
  • Eli Lilly’s Retatrutide Surges Ahead in Weight Loss Race, Outperforming Novo Nordisk’s Ozempic in Landmark Trial
  • Reclaiming Intimacy: Navigating Sexual Health After Breast Cancer Treatment
  • Breakthroughs in Breast Cancer: Key Insights from the ESMO Annual Congress
  • Strengthening the Global Health Architecture: A Deep Dive into the WHO-Netherlands Strategic Dialogue

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

unmasking-the-silent-threat-groundbreaking-st-jude-research-reveals-genetic-blueprint-of-secondary-cancers-in-childhood-survivors
  • Medical Research and Clinical Trials

Unmasking the Silent Threat: Groundbreaking St. Jude Research Reveals Genetic Blueprint of Secondary Cancers in Childhood Survivors

Layla Zulfa October 29, 2026
eli-lillys-retatrutide-surges-ahead-in-weight-loss-race-outperforming-novo-nordisks-ozempic-in-landmark-trial
  • Medical Research and Clinical Trials

Eli Lilly’s Retatrutide Surges Ahead in Weight Loss Race, Outperforming Novo Nordisk’s Ozempic in Landmark Trial

Ammar Sabilarrohman October 29, 2026
reclaiming-intimacy-navigating-sexual-health-after-breast-cancer-treatment
  • Patient Advocacy and Support

Reclaiming Intimacy: Navigating Sexual Health After Breast Cancer Treatment

Basiran October 29, 2026
Scientists working with samples in laboratory
  • Patient Advocacy and Support

Breakthroughs in Breast Cancer: Key Insights from the ESMO Annual Congress

Azzam Bilal Chamdy October 29, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.